NephLong
Firendia
Details
10 mg
20 mg
Generic Name: Finerenone
Strength: 10 mg, 20 mg
Product Description:
Firendia Tablet contains Finerenone, a non-steroidal mineralocorticoid receptor antagonist. It is primarily used to treat chronic kidney disease associated with type 2 diabetes and to reduce the risk of cardiovascular events. Finerenone works by blocking the effects of aldosterone, a hormone that can cause inflammation and fibrosis in the kidneys and heart, helping to protect these organs.
Indications:
-
Management of chronic kidney disease in patients with type 2 diabetes
-
Reduction of cardiovascular risk in patients with chronic kidney conditions
Dosage Forms:
Film-coated tablets available in 10 mg and 20 mg strengths.
Mechanism of Action:
Finerenone selectively inhibits mineralocorticoid receptors, reducing inflammation and fibrosis, thereby improving kidney function and cardiovascular outcomes.
Common Side Effects:
-
Hyperkalemia (high potassium levels)
-
Fatigue
-
Dizziness
Precautions:
-
Monitor serum potassium regularly
-
Use cautiously in patients with severe kidney impairment
-
Not recommended during pregnancy or breastfeeding
Keto Nephron™ DS is a Medical Food as defined under 21 U.S.C. §360ee(b)(3) and 21 CFR 101.9(j)(8), formulated for the dietary management of Chronic Kidney Disease (CKD) Stages 3-5 in adults following physician-supervised protein-restricted diets. It is not a drug, not a dietary supplement, and is not intended for self-medication or general wellness use. MUST BE USED UNDER MEDICAL SUPERVISION. Quantum LifeSciences Inc., Claremont, CA 91711, USA. FDA Food Facility (Manufacturer) Reg. No. 14961463490.